- Home
- SVA vs CPAY Comparison
SVA vs CPAY Comparison
Compare SVA & CPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVA
- CPAY
- Stock Information
- Founded
- SVA N/A
- CPAY 1986
- Country
- SVA
- CPAY United States
- Employees
- SVA 3261
- CPAY N/A
- Industry
- SVA
- CPAY EDP Services
- Sector
- SVA
- CPAY Technology
- Exchange
- SVA NYSE
- CPAY Nasdaq
- Market Cap
- SVA N/A
- CPAY N/A
- IPO Year
- SVA N/A
- CPAY 2010
- Fundamental
- Price
- SVA $6.47
- CPAY $308.73
- Analyst Decision
- SVA
- CPAY Buy
- Analyst Count
- SVA 0
- CPAY 12
- Target Price
- SVA N/A
- CPAY $403.64
- AVG Volume (30 Days)
- SVA N/A
- CPAY 515.2K
- Earning Date
- SVA N/A
- CPAY 05-06-2025
- Dividend Yield
- SVA N/A
- CPAY N/A
- EPS Growth
- SVA N/A
- CPAY 5.83
- EPS
- SVA N/A
- CPAY 13.97
- Revenue
- SVA N/A
- CPAY $3,974,589,000.00
- Revenue This Year
- SVA N/A
- CPAY $12.99
- Revenue Next Year
- SVA N/A
- CPAY $10.47
- P/E Ratio
- SVA N/A
- CPAY $22.10
- Revenue Growth
- SVA N/A
- CPAY 5.77
- 52 Week Low
- SVA N/A
- CPAY $247.10
- 52 Week High
- SVA N/A
- CPAY $400.81
- Technical
- Relative Strength Index (RSI)
- SVA N/A
- CPAY 42.68
- Support Level
- SVA N/A
- CPAY $302.79
- Resistance Level
- SVA N/A
- CPAY $314.96
- Average True Range (ATR)
- SVA 0.00
- CPAY 18.91
- MACD
- SVA 0.00
- CPAY -0.36
- Stochastic Oscillator
- SVA 0.00
- CPAY 43.36
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.